Tumor antigen regimens immunotherapy adoptive. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy24

Cell Line, Tumor T-Lymphocytes, Cytotoxic T-Lymphocytes Dendritic Cells CD8-Positive T-Lymphocytes Lymphocytes, Tumor-Infiltrating Cell Line CD4-Positive T-Lymphocytes Cells, Cultured Tumor Cells, Cultured Antigen-Presenting Cells Spleen Clone Cells Lymph Nodes B-Lymphocytes Killer Cells, Natural T-Lymphocytes, Regulatory Lymphocytes Cell Line, Transformed Immune Sera Leukocytes, Mononuclear Pollen T-Lymphocyte Subsets K562 Cells

Organisms11

Simian virus 40 Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic Polyomavirus Polyomaviridae Mice, SCID Mice, Nude Adenoviridae Mice, Inbred Strains Mice, Knockout

Diseases40

Neoplasms, Experimental Neoplasms Melanoma, Experimental Melanoma Sarcoma, Experimental Brain Neoplasms Fibrosarcoma Neoplasm Metastasis Adenocarcinoma Wilms Tumor Mammary Neoplasms, Experimental Kidney Neoplasms Skin Neoplasms Colonic Neoplasms Ovarian Neoplasms Cell Transformation, Neoplastic Rhinitis, Allergic, Seasonal Carcinoid Tumor Disease Models, Animal Lung Neoplasms Carcinoma, Renal Cell Neuroendocrine Tumors Liver Neoplasms Cell Transformation, Viral Lymphoma Breast Neoplasms Neovascularization, Pathologic Disease Progression Glioma Pancreatic Neoplasms Carcinoma, Squamous Cell Glioblastoma Gastrointestinal Stromal Tumors Neoplasm Recurrence, Local Urinary Bladder Neoplasms Hypersensitivity, Delayed Hypersensitivity Carcinoma, Hepatocellular Tumor Virus Infections Neuroblastoma

Chemicals and Drugs96

Antigens, Neoplasm Antigens, Viral, Tumor Antigens Cancer Vaccines Antigens, Polyomavirus Transforming Antigens, Bacterial Antigens, Surface Antigens, Viral Antibodies, Monoclonal HLA-A2 Antigen Tumor Markers, Biological Neoplasm Proteins Tumor Necrosis Factor-alpha Epitopes Antibodies, Neoplasm MART-1 Antigen Carcinoembryonic Antigen HLA-A Antigens gp100 Melanoma Antigen HLA Antigens Antigens, CD Melanoma-Specific Antigens Interferon-gamma Receptors, Antigen, T-Cell Antigens, Protozoan Epitopes, T-Lymphocyte H-2 Antigens Antigens, Tumor-Associated, Carbohydrate Interleukin-2 Tumor Suppressor Protein p53 Immunoglobulin G HLA-DR Antigens Histocompatibility Antigens Class I Antigens, Fungal Histocompatibility Antigens Class II Adjuvants, Immunologic RNA, Messenger Histocompatibility Antigens Antigens, Helminth Recombinant Proteins Mucin-1 Antigens, CD80 Cytokines Peptide Fragments Antigens, CD3 Peptides HLA-A24 Antigen Antibodies Allergens Antigens, CD8 Antineoplastic Agents Receptors, Antigen Proliferating Cell Nuclear Antigen Antigens, CD40 Prostate-Specific Antigen Vaccines, DNA Recombinant Fusion Proteins Tumor Suppressor Proteins Ovalbumin HLA-A1 Antigen CTLA-4 Antigen Cyclophosphamide Antigens, Differentiation Antibodies, Bispecific Membrane Glycoproteins Immunoglobulin E Vaccines, Subunit Receptors, Antigen, B-Cell Autoantigens O Antigens BCG Vaccine Membrane Proteins HLA-A3 Antigen Antigens, CD15 Antibodies, Anti-Idiotypic Oncogene Proteins, Viral Vaccines, Synthetic Immune Sera Antigens, CD4 Granulocyte-Macrophage Colony-Stimulating Factor DNA, Viral Antigens, Plant Interleukin-12 Antigen-Antibody Complex Antigens, CD86 DNA, Neoplasm Antigens, CD45 Bee Venoms Methylcholanthrene Immunoglobulin Fragments Antigens, CD19 Hepatitis B Surface Antigens Glycoproteins Blood Group Antigens Receptors, Antigen, T-Cell, alpha-beta HLA-D Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment49

Immunotherapy Immunotherapy, Adoptive Immunotherapy, Active Desensitization, Immunologic Neoplasms, Experimental Melanoma, Experimental Lymphocyte Activation Tumor Burden Flow Cytometry Treatment Outcome Enzyme-Linked Immunosorbent Assay Sarcoma, Experimental Neoplasm Transplantation Immunization Administration, Sublingual Combined Modality Therapy Mammary Neoplasms, Experimental Transfection Sublingual Immunotherapy Immunization, Passive Disease Models, Animal Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Transplantation, Heterologous Vaccination Immunoenzyme Techniques Fluorescent Antibody Technique Blotting, Western Cytotoxicity Tests, Immunologic Genetic Therapy Xenograft Model Antitumor Assays Neoplasm Staging Clinical Trials as Topic Drug Administration Schedule Survival Analysis Adoptive Transfer Polymerase Chain Reaction Survival Rate Drug Therapy, Combination Monitoring, Immunologic Retrospective Studies Injections, Intralesional Immunophenotyping Sensitivity and Specificity Prognosis Disease-Free Survival Cloning, Molecular Injections, Subcutaneous

Phenomena and Processes40

Lymphocyte Activation Cytotoxicity, Immunologic Antigen Presentation Amino Acid Sequence Time Factors Tumor Microenvironment Immunity, Cellular Tumor Escape Antibody Specificity Cell Proliferation Transfection Base Sequence Genes, Tumor Suppressor Genetic Vectors Cell Division Immune Tolerance Cross Reactions Cross-Priming Mutation Antibody Formation Cell Transformation, Viral Signal Transduction Antigen-Antibody Reactions Phenotype Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Gene Expression Molecular Weight Cell Differentiation Cell Survival Dose-Response Relationship, Immunologic Immunologic Surveillance Tissue Distribution Protein Binding Sensitivity and Specificity Immunologic Memory T-Cell Antigen Receptor Specificity Apoptosis Cell Movement Immunity

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate

Health Care9

Treatment Outcome Immunization Vaccination Clinical Trials as Topic Survival Analysis Survival Rate Retrospective Studies Sensitivity and Specificity Disease-Free Survival

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Immunotherapy Antigens, Neoplasm Antigens, Viral, Tumor Antigens Immunotherapy, Adoptive Cancer Vaccines Immunotherapy, Active Antigens, Polyomavirus Transforming Antigens, Bacterial Antigens, Surface Desensitization, Immunologic Antigens, Viral Cell Line, Tumor Antibodies, Monoclonal Simian virus 40 T-Lymphocytes, Cytotoxic Neoplasms, Experimental Mice, Inbred BALB C T-Lymphocytes Dendritic Cells Neoplasms HLA-A2 Antigen Tumor Markers, Biological Mice, Inbred C57BL CD8-Positive T-Lymphocytes Melanoma, Experimental Melanoma Lymphocyte Activation Neoplasm Proteins Tumor Necrosis Factor-alpha Cytotoxicity, Immunologic Epitopes Tumor Burden Antibodies, Neoplasm MART-1 Antigen Carcinoembryonic Antigen HLA-A Antigens gp100 Melanoma Antigen Lymphocytes, Tumor-Infiltrating HLA Antigens Antigens, CD Cell Line Melanoma-Specific Antigens Molecular Sequence Data Mice, Transgenic Interferon-gamma Flow Cytometry Receptors, Antigen, T-Cell Antigens, Protozoan Treatment Outcome Epitopes, T-Lymphocyte Enzyme-Linked Immunosorbent Assay Antigen Presentation CD4-Positive T-Lymphocytes H-2 Antigens Amino Acid Sequence Sarcoma, Experimental Antigens, Tumor-Associated, Carbohydrate Brain Neoplasms Neoplasm Transplantation Interleukin-2 Fibrosarcoma Tumor Suppressor Protein p53 Immunization Time Factors Neoplasm Metastasis Administration, Sublingual Immunoglobulin G Combined Modality Therapy Polyomavirus Tumor Microenvironment HLA-DR Antigens Adenocarcinoma Histocompatibility Antigens Class I Antigens, Fungal Wilms Tumor Immunity, Cellular Mammary Neoplasms, Experimental Kidney Neoplasms Cells, Cultured Tumor Escape Histocompatibility Antigens Class II Antibody Specificity Skin Neoplasms Tumor Cells, Cultured Cell Proliferation Adjuvants, Immunologic Colonic Neoplasms RNA, Messenger Transfection Histocompatibility Antigens Sublingual Immunotherapy Base Sequence Antigens, Helminth Antigen-Presenting Cells Recombinant Proteins Immunization, Passive Mucin-1 Genes, Tumor Suppressor Genetic Vectors

No FAQ available that match "tumor antigen regimens immunotherapy adoptive"